NNovo Nordisk Read More Novo Nordisk backs India’s sickle cell elimination by 20472026-10-16 Danish pharma giant Novo Nordisk has pledged support for India’s National Sickle Cell Anaemia Elimination Mission, targeting 2047.…
NNovo Nordisk Read More Novo Nordisk’s Bittersweet Victory: EU Backs New Wegovy Forms as Shares Slump and Competition Inte2026-06-02 Despite two CHMP recommendations for oral and high-dose Wegovy in May, Novo Nordisk stock is down 40% over…
NNovo Nordisk Read More Novo Nordisk Races to Close the Efficacy Gap: EU Backs Oral Wegovy as Lilly Posts 28.3% Weight Loss2026-05-25 EU regulator recommends oral and high-dose Wegovy as Novo Nordisk counters Eli Lilly’s 28.3% weight-loss Retatrutide, but efficacy…
NNovo Nordisk Read More Novo Nordisk Turns the Page: EU Backs Oral Wegovy as Liver Disease Data and a DKK 11.2bn Buyback Lif2026-05-25 Novo Nordisk launches DKK 11.2B buyback, receives EU approval for two new Wegovy formulations, posts strong oral tablet…
NNovo Nordisk Read More Novo Nordisk Turns a Corner: EU Panel Backs Both Oral and High-Dose Wegovy as US Sales Surprise2026-05-24 European Medicines Agency backs two Wegovy formulations; oral tablet becomes first GLP-1 pill for weight loss in EU.…